ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) was up 15.2% during trading on Monday . The company traded as high as $0.63 and last traded at $0.63. Approximately 603,206 shares traded hands during mid-day trading, an increase of 2,868% from the average daily volume of 20,327 shares. The stock had previously closed at $0.54.
ImmunoPrecise Antibodies Stock Down 0.8 %
The stock has a fifty day moving average of $0.73 and a 200-day moving average of $1.01.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- Following Congress Stock Trades
- Ciena Stock Powers the AI Cloud Boom—Don’t Miss Out
- Technology Stocks Explained: Here’s What to Know About Tech
- Affirm’s Path to Profitability Elevates with Interest Rate Cuts
- How to Invest in the Best Canadian Stocks
- RPM International Thrives in Rate-Cut Driven Construction Rally
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
